West Homestead, PA, United States of America

Robert Kruger Bressin

This inventor holds 1 USPTO granted patent. Top assignee: University of Pittsburgh. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert Kruger Bressin. Retrieved from https://idiyas.com/inventor/robert-kruger-bressin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Robert Kruger Bressin

Introduction

Robert Kruger Bressin is an accomplished inventor based in West Homestead, Pennsylvania. He has made significant contributions to the field of chemistry, particularly in developing antidotes for organophosphorus nerve agents. His work is crucial in addressing the dangers posed by chemical agents and pesticides.

Latest Patents

Bressin holds a patent for "Analogs of 2-pralidoxime as antidotes against organophosphorus nerve agents." This patent describes compounds that are useful in treating exposure to organophosphorus compounds, such as nerve agents and pesticides. The patent outlines pharmaceutical compositions and dosage forms that comprise these compounds, as well as methods for treating patients exposed to such harmful agents.

Career Highlights

Bressin is affiliated with the University of Pittsburgh, where he conducts research and develops innovative solutions to combat the effects of toxic substances. His work has garnered attention for its potential applications in medical and emergency response settings.

Collaborations

Throughout his career, Bressin has collaborated with notable colleagues, including Kazunori Koide and Kiflai Bein. These partnerships have enhanced his research and contributed to the advancement of antidote development.

Conclusion

Robert Kruger Bressin's contributions to the field of chemistry and his innovative patent for antidotes against nerve agents highlight the importance of research in public safety. His work continues to pave the way for advancements in medical treatments for exposure to hazardous substances.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…